POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

CourtDistrict Court, D. New Jersey
DecidedFebruary 1, 2021
Docket3:15-cv-07658
StatusUnknown

This text of POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC., (D.N.J. 2021).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

MRC LEEUHHORTR 2 Civil Action No. 15-7658 (MAS) (LHG) INTERNATIONAL, INC. SECURITIES LITIGATION MEMORANDUM OPINION

SHIPP, District Judge This matter comes before the Court upon Lead Plaintiff TIAA’s (“Lead Plaintiff”) Motion to Adopt the Special Master’s Report and Recommendation Granting Final Approval of: (1) the Class Action Settlement and Plan of Allocation; and (2) an Award of Attorneys’ Fees and Expenses to Plaintiffs (“Motion to Adopt”). (ECF No. 576.) Class Members Timber Hill LLC (“Timber Hill”) and Cathy Lochridge (“Lochridge”) opposed Lead Plaintiffs Motion to Adopt and objected to the Special Master’s Report and Recommendation. (ECF Nos. 592, 596.) Lead Plaintiff opposed Timber Hill and Lochridge’s objections and replied to their oppositions. (ECF Nos. 595, 601.) Timber Hill and Lochridge replied. (ECF Nos. 599, 603, 604.) The Court has carefully considered the parties’ submissions and decides the matter without oral argument pursuant to Local Civil Rule 78.1. For the reasons set forth herein, Lead Plaintiff's Motion to Adopt is granted. i. BACKGROUND The Court previously summarized many of the factual allegations at issue in this matter and the Court assumes the parties’ familiarity with those allegations. See, e.g..Jn re Valeant Pharms. Int'l, Inc. Sec. Litig. (“In re Valeant’”), No. 15-7658, 2017 WL 1658822 (D.N.J. Apr. 28,

2017), recons. denied, No. 15-7658, 2017 WL 3880657 (D.N.J. Sept. 5, 2017). The Court, therefore, only recounts those facts necessary to resolve the instant Motion. On October 22, 2015, Laura Potter, on “behalf of all persons who purchased or otherwise acquired Valeant stock between February 23, 2015 and October 20, 2015,” brought a putative class action “against Valeant and certain of its officers and/or directors for violations of the Securities Exchange Act of 1934[.]” (In re Valeant Pharms. Int'l, Inc. Sec. Litig. (*Valeant Class Action’), No. 15-7658 (D.N.J.), Compl. § 1, ECF No. 1.) On May 31, 2016, the Court consolidated Ms. Potter's action with several other actions, and pursuant to the Private Securities Litigation Reform Act (“PSLRA”), 15 U.S.C. § 78u-4, the Court appointed Lead Plaintiff and Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) as Lead Counsel in the consolidated action.' (Valeant Class Action, Order, ECF No. 67.) On June 24, 2016, Lead Plaintiff filed a Consolidated Complaint (Valeant Class Action, Consol. Compl., ECF No. 80.) On April 28, 2017, the Court decided six motions to dismiss filed by various groups of defendants in the Valeant Class Action. See In re Valeant, 2017 WL 1658822, at *1. On September 20, 2018, Lead Plaintiff filed the First Amended Class Complaint naming additional defendants and bringing additional claims. (Valeant Class Action, First Am. Class Compl., ECF No. 352.) Meanwhile, on June 6, 2018, Timber Hill filed a class action complaint on behalf of all “persons and entities that purchased call options on Valeant . .. common stock and/or sold put options on Valeant common stock[.]” (Timber Hill LLC v. Valeant Pharms. Int'l, Inc., No. 18-10246 (D.N.J.), Compl., ECF No, 1.) The Court consolidated Timber Hill’s complaint with the Valeant Class Action for pretrial purposes. (ECF No. 318.) On September 10, 2019, the Court

' Lead Plaintiff retained Robbins Geller as counsel “and negotiated a fee agreement with Robbins Geller at the outset of the case.” (Gomez Decl. § 5, ECF No. 539-21.) Under Lead Plaintiff's “agreement with Lead Counsel, there is also an overall fee cap of 13%.” (/d.)

entered an Order referring this matter to Special Master Dennis M. Cavanaugh, U.S.D.J. (ret.) (“Special Master”). (ECF No. 484.) During the course of this litigation, the settling parties engaged in two mediation sessions with Professor Eric D. Green, Esq. (“Dr. Green”). On November 22, 2019, the settling parties accepted Professor Green’s mediator’s proposal “agreeing to settle the claims against all Defendants and Former Defendants, except PwC, in the amount of $1,210,000,000.” (Barz Decl. © 9, ECF No. 539-3.) On December 15, 2019, Lead Plaintiff, on behalf of itself and the Class, and the settling defendants entered into a Stipulation of Settlement. On December 17, 2019, Lead Plaintiff moved for preliminary approval of the Valeant Class Action. On January 24, 2020, the Special Master entered an order granting preliminary approval. (ECF No. 510.) On February 5, 2020, the Court adopted the Special Master’s order granting preliminary approval of the settlement. (ECF No. 515.) Notice of the proposed class was then performed in accordance with the preliminary approval order. According to the Declaration of Ross D. Murray submitted by Lead Counsel, as of April 20, 2020, a total of 431,576 packages consisting of the Notice of Proof of Claim and Release Form (“Notice Package”) were mailed to potential class members and nominees. (Murray Decl. £11, ECF No. 539-24.) Notice was also transmitted over Business Wire and published in The Wall Street Journal. (/d. § 12.) The Notice Package, Stipulation of Settlement, Preliminary Approval Order, and other relevant documents were also posted on a website dedicated to the litigation and settlement. (/d. {§ 13-14.) Four objections to settlement were received by the Court: two relating to the Attorneys’ Fee Request, including Lochridge’s objection; one to the amount of settlement; and Timber Hill’s objection to the settlement and Plan of Allocation (“POA”).

On June 15, 2020, the Special Master issued a report recommending approval of the settlement and POA, and an award of attorneys’ fees and expenses. (see generally June 2020 Report and Recommendation (“June 2020 R&R”), ECF No. 575.) Lochridge objects to the requested fee award and Timber Hill objects to the settlement and POA. The other two individuals have not objected. Il. LEGAL STANDARD The Court reviews objections to the Special Master's findings of fact and conclusions of law de novo. (Order 4, ECF No. 484); Fed. R. Civ. P. 53(f)(3)-(4). The Court “may adopt or affirm, modify, wholly or partly reject or reverse, or resubmit to the master with instructions.” Fed. R. Civ. P. 53(f)(1); (Order 4, ECF No. 484.) ill. DISCUSSION A. Settlement and Plan of Allocation Timber Hill objects to the Special Master’s recommendation to approve the settlement and POA. (Timber Hill's Objection to Report & Recommendation (“OR&R”) 6, ECF No, 592.) Despite previously approving of an allocation in the 5.35% range, Timber Hill now argues that the POA imposes an arbitrary 5% recovery cap on options investors while common stock and debt investors are permitted to recover from the remaining 95% on a pro rata basis. (/d. at 1-2, 15.) According to Timber Hill, the “options cap reflects a fundamental conflict concerning the allocation of [s]ettlement proceeds and demonstrates that [o]ptions [i]nvestors were inadequately represented.” (/d. at 2-3.) Timber Hill asserts that the POA should be amended to remove the 5%

cap or, alternatively, to increase the cap to 9.49%,? (Id.) The Court disagrees with Timber Hill's

arguments and, for the following reasons, overrules its objection. l. The POA is Fair, Reasonable, and Adequate The “[a]pproval of a plan of allocation of a settlement fund in a class action is governed by the same standards of review applicable to approval of the settlement as a whole: the distribution plan must be fair, reasonable and adequate.” Demmick v. Cellco P'Ship, No. 06-2163, 2015 WL 13643682, at *10 (D.N.J.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/potter-v-valeant-pharmaceuticals-international-inc-njd-2021.